首页> 外文期刊>Urology >Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.
【24h】

Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.

机译:上尿路尿道癌:WHO / ISUP 1998共识分类与WHO 1999分类系统的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To compare the usefulness of World Health Organization (WHO)/International Society of Urological Pathologists 1998 consensus classification with the WHO 1999 classification in a large series of urothelial tumors of the upper urinary tract. Only a few bladder tumor studies have compared these systems. METHODS: A clinical and histopathologic review was performed of all patients diagnosed in western Sweden between 1971 and 1998 with renal pelvic or ureteral carcinoma. We selected 555 surgically treated patients who all had a urothelial tumor on review of the pathologic findings and no bladder tumor before diagnosis of the upper tract tumor. The median follow-up was 52 months. Disease-specific survival was calculated using Kaplan-Meier estimates. RESULTS: A total of 349 patients had Stage pTa, pT1, or pT2 tumor, with a 5-year disease-specific survival rate of 95%, 80%, and 79%, respectively. No significant difference was found in the prognosis among papillary urothelial neoplasm of low malignant potential and low-grade and high-grade tumors of the same stage. Nor was a difference found among papillary urothelial neoplasm of low malignant potential and grade 1, 2, and 3 tumors. Of the 349 patients, 171, all with high-grade Stage pT3 tumors, had a 35% disease-specific survival rate. Of these tumors, 38 were grade 2 and 133 were grade 3, with a survival rate of 49% and 25%, respectively (P <0.0037). All 35 pT4 tumors were high grade, and no patient survived past 30 months. CONCLUSIONS: Tumor stage was a very strong predictor of prognosis in this series of patients treated with open surgery. The tumor grade had little additional prognostic value, although a small advantage was found for the WHO 1999 classification, but only for high-grade, Stage pT3 tumors.
机译:目的:比较世界卫生组织(WHO)/国际泌尿外科病理学家学会1998年共识分类与WHO 1999年分类在上尿路大面积尿路上皮肿瘤中的作用。只有少数膀胱肿瘤研究比较了这些系统。方法:对1971年至1998年在瑞典西部诊断出的所有患有肾盂癌或输尿管癌的患者进行了临床和组织病理学检查。我们回顾了555例经手术治疗的患者,这些患者均经病理学检查后均诊断为尿路上皮肿瘤,在诊断上道肿瘤之前无膀胱肿瘤。中位随访52个月。使用Kaplan-Meier估计值计算特定疾病的生存期。结果:共有349例患者患有pTa,pT1或pT2期肿瘤,其5年疾病特异性存活率分别为95%,80%和79%。低恶性潜力的乳头状尿路上皮肿瘤与同一阶段的低度和高度肿瘤的预后没有发现显着差异。低恶性潜力的乳头状尿路上皮肿瘤与1、2和3级肿瘤之间也没有发现差异。在349例患者中,有171例均患有高级pT3期肿瘤,其疾病特异性生存率为35%。在这些肿瘤中,38例为2级,133例为3级,生存率分别为49%和25%(P <0.0037)。所有35个pT4肿瘤均为高级别,并且没有患者在30个月后幸存。结论:在这一系列接受开腹手术的患者中,肿瘤的分期是非常强的预后指标。肿瘤分级具有附加的预后价值,尽管在WHO 1999分类中发现了很小的优势,但仅适用于高度分级的pT3期肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号